Endogenous anticancer mechanisms (EACMs)

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 3, 2012, Pages 1017-1030

  Lenz, Guido ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Anticancer mechanisms; Apoptosis; Autophagy; Cell cycle; DNA repair; Invasion; Review; Senescence; Tumor suppressor mechanisms

Indexed keywords

ATG4C; ATM PROTEIN; BECLIN 1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOCHROME C; GAMMA INTERFERON; INTERLEUKIN DERIVATIVE; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SURVIVIN; TELOMERASE; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UVOMORULIN; X LINKED INHIBITOR OF APOPTOSIS; XERODERMA PIGMENTOSUM PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CANCER THERAPY; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; CELL CYCLE REGULATION; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; ENDOGENOUS ANTICANCER MECHANISM; EXCISION REPAIR; GENE ACTIVATION; GENOMIC INSTABILITY; HUMAN; IMMUNOSURVEILLANCE; MOLECULAR PATHOLOGY; NONHUMAN; NUCLEAR REPROGRAMMING; PROTEIN EXPRESSION; SENESCENCE; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; ANIMAL; CELL AGING; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL AGING; HUMANS; NEOPLASMS;

EID: 84869443686     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s315     Document Type: Article

References (108)

1. Hanahan, D. & R. A. Weinberg: Hallmarks of cancer: the next generation. Cell, 144, 646-74 (2011)
2. Matei, I. R., C. J. Guidos & J. S. Danska: ATMdependent DNA damage surveillance in T-cell development and leukemogenesis: the DSB connection. Immunol Rev, 209, 142-58 (2006)
3. Shiloh, Y.: ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer, 3, 155-68 (2003) (Pubitemid 37328868)
4. Cleaver, J. E.: Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer, 5, 564-73 (2005) (Pubitemid 40942832)
5. Mastrangelo, D., S. De Francesco, A. Di Leonardo, L. Lentini & T. Hadjistilianou: Retinoblastoma epidemiology: does the evidence matter? Eur J Cancer, 43, 1596-603 (2007) (Pubitemid 46891808)
6. Lin, P. P., M. K. Pandey, F. Jin, A. K. Raymond, H. Akiyama & G. Lozano: Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice. Carcinogenesis, 30, 1789-95 (2009)
7. Abbas, T. & A. Dutta: p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer, 9, 400-14 (2009)
8. Kang, J. U., S. H. Koo, K. C. Kwon, J. W. Park & J. M. Kim: Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet, 182, 1-11 (2008) (Pubitemid 351323956)
9. Rafnar, T., P. Sulem, S. N. Stacey, F. Geller, J. Gudmundsson, A. Sigurdsson, M. Jakobsdottir, H. Helgadottir, S. Thorlacius, K. K. Aben, T. Blondal, T. E. Thorgeirsson, G. Thorleifsson, K. Kristjansson, K. Thorisdottir, R. Ragnarsson, B. Sigurgeirsson, H. Skuladottir, T. Gudbjartsson, H. J. Isaksson, G. V. Einarsson, K. R. Benediktsdottir, B. A. Agnarsson, K. Olafsson, A. Salvarsdottir, H. Bjarnason, M. Asgeirsdottir, K. T. Kristinsson, S. Matthiasdottir, S. G. Sveinsdottir, S. Polidoro, V. Hoiom, R. Botella-Estrada, K. Hemminki, P. Rudnai, D. T. Bishop, M. Campagna, E. Kellen, M. P. Zeegers, P. de Verdier, A. Ferrer, D. Isla, M. J. Vidal, R. Andres, B. Saez, P. Juberias, J. Banzo, S. Navarrete, A. Tres, D. Kan, A. Lindblom, E. Gurzau, K. Koppova, F. de Vegt, J. A. Schalken, H. F. van der Heijden, H. J. Smit, R. A. Termeer, E. Oosterwijk, O. van Hooij, E. Nagore, S. Porru, G. Steineck, J. Hansson, F. Buntinx, W. J. Catalona, G. Matullo, P. Vineis, A. E. Kiltie, J. I. Mayordomo, R. Kumar, L. A. Kiemeney, M. L. Frigge, T. Jonsson, H. Saemundsson, R. B. Barkardottir, E. Jonsson, S. Jonsson, J. H. Olafsson, J. R. Gulcher, G. Masson, D. F. Gudbjartsson, A. Kong, U. Thorsteinsdottir & K. Stefansson: Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet, 41, 221-7 (2009)
10. Blasco, M. A.: Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet, 6, 611-22 (2005) (Pubitemid 41044298)
11. Gonzalez-Suarez, E., J. M. Flores & M. A. Blasco: Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development. Mol Cell Biol, 22, 7291-301 (2002)
12. Gonzalez-Suarez, E., E. Samper, J. M. Flores & M. A. Blasco: Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet, 26, 114-7 (2000)
13. Negrini, S., V. G. Gorgoulis & T. D. Halazonetis: Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol, 11, 220-8 (2010)
14. Sharpless, N. E.: INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res, 576, 22-38 (2005) (Pubitemid 40982680)
15. Danial, N. N. & S. J. Korsmeyer: Cell death: critical control points. Cell, 116, 205-19 (2004) (Pubitemid 38167313)
16. Tamm, I., S. Richter, D. Oltersdorf, U. Creutzig, J. Harbott, F. Scholz, L. Karawajew, W. D. Ludwig & C. Wuchter: High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin Cancer Res, 10, 3737-44 (2004) (Pubitemid 38697607)
17. Mizutani, Y., H. Nakanishi, Y. N. Li, H. Matsubara, K. Yamamoto, N. Sato, T. Shiraishi, T. Nakamura, K. Mikami, K. Okihara, N. Takaha, O. Ukimura, A. Kawauchi, N. Nonomura, B. Bonavida & T. Miki: Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis. Int J Oncol, 30, 919-25 (2007)
18. Elhasid, R., D. Sahar, A. Merling, Y. Zivony, A. Rotem, M. Ben-Arush, S. Izraeli, D. Bercovich & S. Larisch: Mitochondrial pro-apoptotic ARTS protein is lost in the majority of acute lymphoblastic leukemia patients. Oncogene, 23, 5468-75 (2004) (Pubitemid 39044057)
19. Gottfried, Y., E. Voldavsky, L. Yodko, E. Sabo, O. Ben-Itzhak & S. Larisch: ARTS in astrocytic tumors: correlation with malignancy grade and survival rate. Cancer, 101, 2614-21 (2004)
20. Garcia-Fernandez, M., H. Kissel, S. Brown, T. Gorenc, A. J. Schile, S. Rafii, S. Larisch & H. Steller: Sept4/ARTS is required for stem cell apoptosis and tumor suppression. Genes Dev, 24, 2282-93 (2010)
21. Liang, X. H., S. Jackson, M. Seaman, K. Brown, B. Kempkes, H. Hibshoosh & B. Levine: Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 402, 672-6 (1999) (Pubitemid 129516338)
22. Chen, Y., Y. Lu, C. Lu & L. Zhang: Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression. Pathol Oncol Res, 15, 487-93 (2009)
23. Nicotra, G., F. Mercalli, C. Peracchio, R. Castino, C. Follo, G. Valente & C. Isidoro: Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas. Mod Pathol, 23, 937-50 (2010)
24. Kim, H. S., S. H. Lee, S. I. Do, S. J. Lim, Y. K. Park & Y. W. Kim: Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma. Pathol Res Pract, 207, 247-52 (2011)
25. Wan, X. B., X. J. Fan, M. Y. Chen, J. Xiang, P. Y. Huang, L. Guo, X. Y. Wu, J. Xu, Z. J. Long, Y. Zhao, W. H. Zhou, H. Q. Mai, Q. Liu & M. H. Hong: Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy, 6, 395-404 (2010)
26. Qu, X., J. Yu, G. Bhagat, N. Furuya, H. Hibshoosh, A. Troxel, J. Rosen, E. L. Eskelinen, N. Mizushima, Y. Ohsumi, G. Cattoretti & B. Levine: Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest, 112, 1809-20 (2003) (Pubitemid 38063704)
27. Yue, Z., S. Jin, C. Yang, A. J. Levine & N. Heintz: Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A, 100, 15077-82 (2003) (Pubitemid 37518019)
28. Marino, G., N. Salvador-Montoliu, A. Fueyo, E. Knecht, N. Mizushima & C. Lopez-Otin: Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem, 282, 18573-83 (2007) (Pubitemid 47100226)
29. Schoenhals, M., A. Kassambara, J. De Vos, D. Hose, J. Moreaux & B. Klein: Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun, 383, 157-62 (2009)
30. Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter & R. L. Brinster: The c-myc malignancy in transgenic mice. Nature, 318, 533-8 (1985)
31. Krizhanovsky, V. & S. W. Lowe: Stem cells: The promises and perils of p53. Nature, 460, 1085-6 (2009)
32. Goh, A. M., C. R. Coffill & D. P. Lane: The role of mutant p53 in human cancer. J Pathol, 223, 116-26 (2011)
33. Mizuno, H., B. T. Spike, G. M. Wahl & A. J. Levine: Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Proc Natl Acad Sci U S A, 107, 22745-50 (2010)
34. Matheu, A., A. Maraver & M. Serrano: The Arf/p53 pathway in cancer and aging. Cancer Res, 68, 6031-4 (2008)
35. Umbas, R., W. B. Isaacs, P. P. Bringuier, H. E. Schaafsma, H. F. Karthaus, G. O. Oosterhof, F. M. Debruyne & J. A. Schalken: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res, 54, 3929-33 (1994) (Pubitemid 24241218)
36. Oka, H., H. Shiozaki, K. Kobayashi, M. Inoue, H. Tahara, T. Kobayashi, Y. Takatsuka, N. Matsuyoshi, S. Hirano, M. Takeichi & et al.: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res, 53, 1696-701 (1993) (Pubitemid 23113254)
37. Onder, T. T., P. B. Gupta, S. A. Mani, J. Yang, E. S. Lander & R. A. Weinberg: Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res, 68, 3645-54 (2008)
38. White, N. M., E. Fatoohi, M. Metias, K. Jung, C. Stephan & G. M. Yousef: Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol, 8, 75-84 (2011)
39. Valastyan, S. & R. A. Weinberg: MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis. Cell Cycle, 8, 3506-12 (2009)
40. Valastyan, S., F. Reinhardt, N. Benaich, D. Calogrias, A. M. Szasz, Z. C. Wang, J. E. Brock, A. L. Richardson & R. A. Weinberg: A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 137, 1032-46 (2009)
41. Boshoff, C. & R. Weiss: AIDS-related malignancies. Nat Rev Cancer, 2, 373-82 (2002) (Pubitemid 37328950)
42. Feichtinger, H., P. Putkonen, C. Parravicini, S. L. Li, E. E. Kaaya, D. Bottiger, G. Biberfeld & P. Biberfeld: Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. Am J Pathol, 137, 1311-5 (1990)
43. Moloney, F. J., H. Comber, P. O'Lorcain, P. O'Kelly, P. J. Conlon & G. M. Murphy: A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol, 154, 498-504 (2006) (Pubitemid 43382659)
44. Shankaran, V., H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson, L. J. Old & R. D. Schreiber: IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature, 410, 1107-11 (2001) (Pubitemid 32391043)
45. Dombernowsky, S. L., M. Weischer, K. H. Allin, S. E. Bojesen, A. Tybjaerg-Hansen & B. G. Nordestgaard: Risk of cancer by ATM missense mutations in the general population. J Clin Oncol, 26, 3057-62 (2008)
46. Rosenberg, P. S., B. P. Alter & W. Ebell: Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry. Haematologica, 93, 511-7 (2008) (Pubitemid 351536378)
47. Howlett, N. G., T. Taniguchi, S. Olson, B. Cox, Q. Waisfisz, C. De Die-Smulders, N. Persky, M. Grompe, H. Joenje, G. Pals, H. Ikeda, E. A. Fox & A. D. D'Andrea: Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297, 606-9 (2002) (Pubitemid 34815345)
48. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer, 83, 1301-8 (2000)
49. Liu, X., H. Holstege, H. van der Gulden, M. Treur-Mulder, J. Zevenhoven, A. Velds, R. M. Kerkhoven, M. H. van Vliet, L. F. Wessels, J. L. Peterse, A. Berns & J. Jonkers: Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci U S A, 104, 12111-6 (2007) (Pubitemid 47185638)
50. Dolan, M. E., R. C. Moschel & A. E. Pegg: Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci U S A, 87, 5368-72 (1990)
51. Bapat, A., L. S. Glass, M. Luo, M. L. Fishel, E. C. Long, M. M. Georgiadis & M. R. Kelley: Novel smallmolecule inhibitor of apurinic/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells. J Pharmacol Exp Ther, 334, 988-98 (2010)
52. Sakaue-Sawano, A., H. Kurokawa, T. Morimura, A. Hanyu, H. Hama, H. Osawa, S. Kashiwagi, K. Fukami, T. Miyata, H. Miyoshi, T. Imamura, M. Ogawa, H. Masai & A. Miyawaki: Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell, 132, 487-98 (2008) (Pubitemid 351191996)
53. Sherr, C. J. & J. M. Roberts: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev, 13, 1501-12 (1999) (Pubitemid 29297917)
54. Vermeulen, K., D. R. Van Bockstaele & Z. N. Berneman: The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif, 36, 131-49 (2003) (Pubitemid 36808270)
55. Jordan, M. A. & L. Wilson: Microtubules as a target for anticancer drugs. Nat Rev Cancer, 4, 253-65 (2004) (Pubitemid 38525281)
56. Schwartz, G. K. & M. A. Shah: Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol, 23, 9408-21 (2005)
57. Diaz-Padilla, I., L. L. Siu & I. Duran: Cyclin-dependent kinase inhibitors as potential targeted anticancer agents. Invest New Drugs (2009)
58. Collado, M. & M. Serrano: Senescence in tumours: evidence from mice and humans. Nat Rev Cancer, 10, 51-7 (2010)
59. Artandi, S. E. & R. A. DePinho: Telomeres and telomerase in cancer. Carcinogenesis, 31, 9-18 (2010)
60. Kuilman, T., C. Michaloglou, W. J. Mooi & D. S. Peeper: The essence of senescence. Genes Dev, 24, 2463-79 (2010)
61. McDuff, F. K. & S. D. Turner: Jailbreak: oncogeneinduced senescence and its evasion. Cell Signal, 23, 6-13 (2011)
62. Zhang, H., B. S. Herbert, K. H. Pan, J. W. Shay & S. N. Cohen: Disparate effects of telomere attrition on gene expression during replicative senescence of human mammary epithelial cells cultured under different conditions. Oncogene, 23, 6193-8 (2004) (Pubitemid 39215289)
63. Roninson, I. B.: Tumor cell senescence in cancer treatment. Cancer Res, 63, 2705-15 (2003) (Pubitemid 36667137)
64. Zamin, L. L., E. C. Filippi-Chiela, P. Dillenburg-Pilla, F. Horn, C. Salbego & G. Lenz: Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci, 100, 1655-62 (2009)
65. Courtois-Cox, S., S. L. Jones & K. Cichowski: Many roads lead to oncogene-induced senescence. Oncogene, 27, 2801-9 (2008) (Pubitemid 351620451)
66. Sun, P., N. Yoshizuka, L. New, B. A. Moser, Y. Li, R. Liao, C. Xie, J. Chen, Q. Deng, M. Yamout, M. Q. Dong, C. G. Frangou, J. R. Yates, 3rd, P. E. Wright & J. Han: PRAK is essential for ras-induced senescence and tumor suppression. Cell, 128, 295-308 (2007) (Pubitemid 46123511)
67. D. Micco, R., M. Fumagalli, A. Cicalese, S. Piccinin, P. Gasparini, C. Luise, C. Schurra, M. Garre, P. G. Nuciforo, A. Bensimon, R. Maestro, P. G. Pelicci & F. d'Adda di Fagagna: Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature, 444, 638-42 (2006) (Pubitemid 44864443)
68. Bartkova, J., N. Rezaei, M. Liontos, P. Karakaidos, D. Kletsas, N. Issaeva, L. V. Vassiliou, E. Kolettas, K. Niforou, V. C. Zoumpourlis, M. Takaoka, H. Nakagawa, F. Tort, K. Fugger, F. Johansson, M. Sehested, C. L. Andersen, L. Dyrskjot, T. Orntoft, J. Lukas, C. Kittas, T. Helleday, T. D. Halazonetis, J. Bartek & V. G. Gorgoulis: Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature, 444, 633-7 (2006) (Pubitemid 44864442)
69. Kuilman, T. & D. S. Peeper: Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer, 9, 81-94 (2009)
70. Wajapeyee, N., R. W. Serra, X. Zhu, M. Mahalingam & M. R. Green: Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell, 132, 363-74 (2008) (Pubitemid 351191995)
71. Villunger, A., E. M. Michalak, L. Coultas, F. Mullauer, G. Bock, M. J. Ausserlechner, J. M. Adams & A. Strasser: p53-and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science, 302, 1036-8 (2003) (Pubitemid 37386194)
72. Tang, D., M. T. Lotze, R. Kang & H. J. Zeh: Apoptosis promotes early tumorigenesis. Oncogene, 30, 1851-4 (2011)
73. LaCasse, E. C., D. J. Mahoney, H. H. Cheung, S. Plenchette, S. Baird & R. G. Korneluk: IAP-targeted therapies for cancer. Oncogene, 27, 6252-75 (2008)
74. Fesik, S. W.: Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer, 5, 876-85 (2005) (Pubitemid 41746032)
75. Oltersdorf, T., S. W. Elmore, A. R. Shoemaker, R. C. Armstrong, D. J. Augeri, B. A. Belli, M. Bruncko, T. L. Deckwerth, J. Dinges, P. J. Hajduk, M. K. Joseph, S. Kitada, S. J. Korsmeyer, A. R. Kunzer, A. Letai, C. Li, M. J. Mitten, D. G. Nettesheim, S. Ng, P. M. Nimmer, J. M. O'Connor, A. Oleksijew, A. M. Petros, J. C. Reed, W. Shen, S. K. Tahir, C. B. Thompson, K. J. Tomaselli, B. Wang, M. D. Wendt, H. Zhang, S. W. Fesik & S. H. Rosenberg: An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature, 435, 677-81 (2005) (Pubitemid 40825512)
76. Degenhardt, K., R. Mathew, B. Beaudoin, K. Bray, D. Anderson, G. Chen, C. Mukherjee, Y. Shi, C. Gelinas, Y. Fan, D. A. Nelson, S. Jin & E. White: Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell, 10, 51-64 (2006)
77. Lomonaco, S. L., S. Finniss, C. Xiang, A. Decarvalho, F. Umansky, S. N. Kalkanis, T. Mikkelsen & C. Brodie: The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer, 125, 717-22 (2009)
78. Eisenberg-Lerner, A., S. Bialik, H. U. Simon & A. Kimchi: Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ, 16, 966-75 (2009)
79. Chen, N. & J. Debnath: Autophagy and tumorigenesis. FEBS Lett, 584, 1427-35 (2010)
80. Sivridis, E., M. I. Koukourakis, S. E. Mendrinos, A. Karpouzis, A. Fiska, C. Kouskoukis & A. Giatromanolaki: Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1. Melanoma Res, 21, 188-95 (2011)
81. Young, A. R., M. Narita, M. Ferreira, K. Kirschner, M. Sadaie, J. F. Darot, S. Tavare, S. Arakawa, S. Shimizu, F. M. Watt & M. Narita: Autophagy mediates the mitotic senescence transition. Genes Dev, 23, 798-803 (2009)
82. Levine, B.: Cell biology: autophagy and cancer. Nature, 446, 745-7 (2007) (Pubitemid 46582063)
83. Takahashi, K. & S. Yamanaka: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-76 (2006) (Pubitemid 44233629)
84. Lenz, G.: Transient oncogenes. Med Hypotheses, 75, 660-2 (2010)
85. Bao, S., Q. Wu, R. E. McLendon, Y. Hao, Q. Shi, A. B. Hjelmeland, M. W. Dewhirst, D. D. Bigner & J. N. Rich: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-60 (2006) (Pubitemid 44949604)
86. Gilbert, L. A. & M. T. Hemann: DNA damagemediated induction of a chemoresistant niche. Cell, 143, 355-66 (2010)
87. Diamandis, P., J. Wildenhain, I. D. Clarke, A. G. Sacher, J. Graham, D. S. Bellows, E. K. Ling, R. J. Ward, L. G. Jamieson, M. Tyers & P. B. Dirks: Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol, 3, 268-73 (2007) (Pubitemid 46625832)
88. Talmadge, J. E. & I. J. Fidler: AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res, 70, 5649-69 (2010)
89. Thiery, J. P., H. Acloque, R. Y. Huang & M. A. Nieto: Epithelial-mesenchymal transitions in development and disease. Cell, 139, 871-90 (2009)
90. Frisch, S. M. & R. A. Screaton: Anoikis mechanisms. Curr Opin Cell Biol, 13, 555-62 (2001) (Pubitemid 32817013)
91. Ribatti, D.: Endogenous inhibitors of angiogenesis: a historical review. Leuk Res, 33, 638-44 (2009)
92. Polyak, K., I. Haviv & I. G. Campbell: Co-evolution of tumor cells and their microenvironment. Trends Genet, 25, 30-8 (2009)
93. Vesely, M. D., M. H. Kershaw, R. D. Schreiber & M. J. Smyth: Natural Innate and Adaptive Immunity to Cancer. Annu Rev Immunol (2010)
94. Rosenberg, S. A., N. P. Restifo, J. C. Yang, R. A. Morgan & M. E. Dudley: Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer, 8, 299-308 (2008) (Pubitemid 351430867)
95. Leroi, A. M., V. Koufopanou & A. Burt: Cancer selection. Nat Rev Cancer, 3, 226-31 (2003) (Pubitemid 37328874)
96. Nairn, R. S., S. Kazianis, B. B. McEntire, L. Della Coletta, R. B. Walter & D. C. Morizot: A CDKN2-like polymorphism in Xiphophorus LG V is associated with UV-B-induced melanoma formation in platyfish-swordtail hybrids. Proc Natl Acad Sci U S A, 93, 13042-7 (1996)
97. Weis, S. & M. Schartl: The macromelanophore locus and the melanoma oncogene Xmrk are separate genetic entities in the genome of Xiphophorus. Genetics, 149, 1909-20 (1998) (Pubitemid 28375960)
98. Campisi, J. & F. d'Adda di Fagagna: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol, 8, 729-40 (2007) (Pubitemid 47312822)
99. Meier, P., A. Finch & G. Evan: Apoptosis in development. Nature, 407, 796-801 (2000)
100. Baehrecke, E. H.: How death shapes life during development. Nat Rev Mol Cell Biol, 3, 779-87 (2002)
101. Santamaria, D., C. Barriere, A. Cerqueira, S. Hunt, C. Tardy, K. Newton, J. F. Caceres, P. Dubus, M. Malumbres & M. Barbacid: Cdk1 is sufficient to drive the mammalian cell cycle. Nature, 448, 811-5 (2007) (Pubitemid 47266342)
102. Beroukhim, R., C. H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, J. Donovan, J. Barretina, J. S. Boehm, J. Dobson, M. Urashima, K. T. Mc Henry, R. M. Pinchback, A. H. Ligon, Y. J. Cho, L. Haery, H. Greulich, M. Reich, W. Winckler, M. S. Lawrence, B. A. Weir, K. E. Tanaka, D. Y. Chiang, A. J. Bass, A. Loo, C. Hoffman, J. Prensner, T. Liefeld, Q. Gao, D. Yecies, S. Signoretti, E. Maher, F. J. Kaye, H. Sasaki, J. E. Tepper, J. A. Fletcher, J. Tabernero, J. Baselga, M. S. Tsao, F. Demichelis, M. A. Rubin, P. A. Janne, M. J. Daly, C. Nucera, R. L. Levine, B. L. Ebert, S. Gabriel, A. K. Rustgi, C. R. Antonescu, M. Ladanyi, A. Letai, L. A. Garraway, M. Loda, D. G. Beer, L. D. True, A. Okamoto, S. L. Pomeroy, S. Singer, T. R. Golub, E. S. Lander, G. Getz, W. R. Sellers & M. Meyerson: The landscape of somatic copy-number alteration across human cancers. Nature, 463, 899-905
103. Garcia-Cao, I., M. Garcia-Cao, J. Martin-Caballero, L. M. Criado, P. Klatt, J. M. Flores, J. C. Weill, M. A. Blasco & M. Serrano: "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. Embo J, 21, 6225-35 (2002) (Pubitemid 35415339)
104. Loos, B. & A. M. Engelbrecht: Cell death: a dynamic response concept. Autophagy, 5, 590-603 (2009)
105. Vlashi, E., K. Kim, C. Lagadec, L. D. Donna, J. T. McDonald, M. Eghbali, J. W. Sayre, E. Stefani, W. McBride & F. Pajonk: In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst, 101, 350-9 (2009)
106. Okada, H. & T. W. Mak: Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer, 4, 592-603 (2004) (Pubitemid 39025054)
107. Degterev, A., M. Boyce & J. Yuan: A decade of caspases. Oncogene, 22, 8543-67 (2003) (Pubitemid 38028527)
108. Youle, R. J. & A. Strasser: The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol, 9, 47-59 (2008)